Formulation and stabilization of magistral collyria
Henschel, V.
Il Farmaco; Edizione Pratica 27(2): 65-79
1972
ISSN/ISBN: 0430-0912 PMID: 5060658 Document Number: 49681
Document emailed within 1 workday
Related Documents
Waikakul, S.; Harnroongroj, T.; Vanadurongwan, V. 1999: Immediate stabilization of unstable pelvic fractures versus delayed stabilization Journal of the Medical Association of Thailand 82(7): 637-642Bulynin, V.I.; Kazanskiĭ, V.N.; Esipenko, V.V.; Martem'ianov, S.V.; Laskarzhevskaia, M.A. 1986: Surgical treatment of magistral vein injuries Vestnik Khirurgii Imeni I. I. Grekova 136(6): 96-99
Kahrilas, P.J. 2003: Conferencia magistral oropharyngeal disorders: diagnosis and treatment Revista de Gastroenterologia de Mexico 68(Suppl 3): 34-39
2002: Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation Prescrire International 11(62): 177-178
2003: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects Prescrire International 12(67): 179
Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
2003: Paracetamol for injection: new formulation. New formulation: why so widely used? Prescrire International 12(67): 178
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
Jehl, F.; Klossek, J.M.; Peynegre, R.; Serrano, E.; Castillo, L.; Bobin, S.; Desprez, D.; Renault, C.; Neel, V.; Rouffiac, E.; Borie, C. 2002: Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily Presse Medicale 31(34): 1596-1603
Goday-Arnó, A.; García Rico, A.; Martínez-Riquelme, A.; Cano-Pérez, J.F. 1996: Graves Basedow disease following treatment with magistral formulae for obesity. Jod-Basedow phenomenon? Revista Clinica Espanola 196(8): 536-538
Hadzović, S. 1994: Use of magistral and galenic drugs as supplements or substitutes for commercially prepared drugs during wartime conditions Medicinski Arhiv 48(2): 47-50
Scheidel, B.; Blume, H.; Walter, K.; von Nieciecki, A.; Babej-Dölle, R.M. 1993: Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation Arzneimittel-Forschung 43(11): 1211-1215
Sedmak, J.J.; Grossberg, S.E. 1977: Stabilization of interferons Texas Reports on Biology and Medicine 35: 198-204
Bhattacharyya, B.; Wolff, J. 1976: Stabilization of microtubules by lithium ion Biochemical and Biophysical Research Communications 73(2): 383-390
Labitzke, R. 1979: Stabilization of the thoracic wall Praxis und Klinik der Pneumologie 33(Suppl 1): 414-415
Kiselev, F.L. 1998: Genes of DNA stabilization and carcinogenesis Molekuliarnaia Biologiia 32(2): 197-205
Regli, F.; Nater, B.; Dworak, N. 1995: Stabilization treatments of migraine Praxis 84(38): 1032-1035
Bennett, G.J. 1992: Osseointegration in spinal stabilization Clinical Neurosurgery 39: 463-474
Schulte, M.; Kinzl, L. 1998: Bone metastases--stabilization as the goal Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115: 134-137